Prescient Therapeutics Limited (AU:PTX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Prescient Therapeutics Limited’s 2024 Annual General Meeting saw the approval of key resolutions, including the election of Dr. Gavin Shepherd and Dr. James Campbell as directors, and the issuance of options to Dr. Shepherd. However, the proposal for a 10% placement facility was not carried, showcasing a significant shareholder dissent.
For further insights into AU:PTX stock, check out TipRanks’ Stock Analysis page.